Business
4basebio Introduces New Branding to Reflect Next Phase of Growth Enabling Development of Advanced Genetic Therapies
CAMBRIDGE, England, July 01, 2025--4basebio PLC (AIM: 4BB) ("4basebio"), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field.
About this update from 4basebio Plc
[{"type":"image","alt":"","displaySize":"","headline":null,"caption":"","credit":null,"className":"","disableSlideshowImg":false,"size":{"original":{"width":899,"height":283,"url":"https://media.zenfs.com/en/business-wire.com/d60892a39f7e6a95e3cfaa1fbe106ad4"},"resized":{"url":"https://s.yimg.com/ny/api/res/1.2/O6BTrMBCRW_h0KW0jr6eYQ--/YXBwaWQ9aGlnaGxhbmRlcjt3PTk2MDtoPTMwMjtjZj13ZWJw/https://media.zenfs.com/en/business-wire.com/d60892a39f7e6a95e3cfaa1fbe106ad4","width":899,"height":283},"lightbox":{"url":"https://s.yimg.com/ny/api/res/1.2/XQfN2jTKUWTwSoPiHwm_Eg--/YXBwaWQ9aGlnaGxhbmRlcjt3PTE3OTg7aD01NjY7Y2Y9d2VicA--/https://media.zenfs.com/en/business-wire.com/d60892a39f7e6a95e3cfaa1fbe106ad4","width":899,"height":283}},"lazy":false},{"type":"text","content":"Expanding capabilities in delivering scalable, high-quality synthetic DNA solutions to the global market","length":104,"tagName":"p","attribs":{}},{"type":"text","content":"CAMBRIDGE, England, July 01, 2025--(BUSINESS WIRE)--4basebio PLC (AIM: 4BB) ("4basebio"), a specialist in synthetic DNA manufacturing and nucleic acids for next-generation therapeutics, today announced refreshed branding and the launch of its new website, reflecting the company’s continued growth and success in this rapidly advancing field.","length":352,"tagName":"p"},{"type":"text","content":"Since completing its £40 million investment in November 2024, 4basebio has achieved several major milestones in its mission to deliver scalable, high-quality synthetic DNA solutions to the global market. Notably, in April this year, the Company received MHRA GMP certification for the manufacture and supply of synthetic DNA for clinical use1.","length":343,"tagName":"p"},{"type":"text","content":"The updated brand identity introduces a refined visual system, including a modernised logo, refreshed colour palette, and a suite of new imagery. The Company’s redesigned website provides a more intuitive access point for partners and customers, providing detailed information and support for 4basebio’s expanding capabilities across synthetic DNA, mRNA, gene editing, and plasmid-free manufacturing. With a newly curated content hub, users can also access a range of specialist resources, including data, whitepapers, articles, case studies and more.","length":551,"tagName":"p"},{"type":"text","content":""This brand refresh marks an excitin...